CVRx Reports Q1 2026 Earnings with Revenue Growth and Operational Expansion
CVRX (NASDAQ:CVRX) reported first-quarter earnings for 2026, showing a revenue increase of $14.8 million driven by U.S. heart failure business expansion. The company also expanded its active implanting centers to 257 and increased sales territories in the U.S.
